Thomas Parks
Directeur Technique/Scientifique/R&D chez University of Utah Research Foundation
Profil
Thomas N.
Parks was the founder of NPS Pharmaceuticals, Inc. founded in 1986, where he held the title of Director from 1986 to 2006.
Currently, he holds multiple positions including Independent Director at Q Therapeutics, Inc. since 2017, Director at SentrX Animal Care, Inc., Director at Navigen, Inc., and Vice President-Research at University of Utah Research Foundation.
Dr. Parks received a doctorate degree from Yale University and an undergraduate degree from the University of California, Irvine.
Postes actifs de Thomas Parks
| Sociétés | Poste | Début |
|---|---|---|
University of Utah Research Foundation
 University of Utah Research Foundation Miscellaneous Commercial ServicesCommercial Services The University of Utah Research Foundation promotes, conducts and facilitates research, development and dissemination, and application of knowledge in the fields of science, technology, medicine, business, education and engineering. The foundation's headquarters is located in Salt Lake City, UT. | Directeur Technique/Scientifique/R&D | 13/06/2011 |
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Directeur/Membre du Conseil | 07/08/2017 |
SentrX Animal Care, Inc.
 SentrX Animal Care, Inc. Pharmaceuticals: MajorHealth Technology SentrX Animal Care, Inc. provides veterinary care services for animals. Its products include gels, film and field treatment kits, film-on-gauzes, adhesion prevention films, spray bottles, and corneal repair gel drops. The company’s products are used for horses, cats and dogs. The company was founded by Richard K. Koehn and Glenn D. Prestwich in 2006 and is headquartered in Salt Lake City, UT. | Directeur/Membre du Conseil | - |
Navigen, Inc.
 Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT. | Directeur/Membre du Conseil | - |
Anciens postes connus de Thomas Parks
| Sociétés | Poste | Fin |
|---|---|---|
| NPS PHARMACEUTICALS, INC. | Fondateur | 01/05/2006 |
Formation de Thomas Parks
| Yale University | Doctorate Degree |
| University of California, Irvine | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
University of Utah Research Foundation
University of Utah Research Foundation Miscellaneous Commercial ServicesCommercial Services The University of Utah Research Foundation promotes, conducts and facilitates research, development and dissemination, and application of knowledge in the fields of science, technology, medicine, business, education and engineering. The foundation's headquarters is located in Salt Lake City, UT. | Commercial Services |
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Health Technology |
SentrX Animal Care, Inc.
SentrX Animal Care, Inc. Pharmaceuticals: MajorHealth Technology SentrX Animal Care, Inc. provides veterinary care services for animals. Its products include gels, film and field treatment kits, film-on-gauzes, adhesion prevention films, spray bottles, and corneal repair gel drops. The company’s products are used for horses, cats and dogs. The company was founded by Richard K. Koehn and Glenn D. Prestwich in 2006 and is headquartered in Salt Lake City, UT. | Health Technology |
Navigen, Inc.
Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT. | Health Technology |